2006
Management of Merkel Cell Carcinoma
Search citation statements
Paper Sections
Select...
14
1
1
0
Citation Types
0
3
0
0
Year Published
2007
2020
Publication Types
Select...
11
5
Relationship
0
16
Authors
Journals
Cited by 16 publications
(3 citation statements)
References 16 publications
0
3
0
0
“…18 With a tripling in the incidence of MCC as discussed above, attention has been given to considering causes contributing to this rise including: improved clinical recognition, 19 the increasing elderly population and a higher number of patients in an immunosupressed state. 20 As defined by its high rate of recurrence, significant risk of metastatic disease and increasing incidence, MCC must be considered in the differential diagnosis of cutaneous malignancy. The diagnosis of MCC can be both clinically and histologically challenging.…”
Section: Discussionmentioning
confidence: 99%
“…18 With a tripling in the incidence of MCC as discussed above, attention has been given to considering causes contributing to this rise including: improved clinical recognition, 19 the increasing elderly population and a higher number of patients in an immunosupressed state. 20 As defined by its high rate of recurrence, significant risk of metastatic disease and increasing incidence, MCC must be considered in the differential diagnosis of cutaneous malignancy. The diagnosis of MCC can be both clinically and histologically challenging.…”
Section: Discussionmentioning
confidence: 99%
“…Histologically, this tumour is classified into trabecular, intermediate and small cell subtype . There is no evidence that the histological features correlate with the clinical outcome . Merkel cell carcinoma Stage I is defined as tumours ≤ 2 cm, Stage II as >2 cm, stage III as regional nodal disease, and stage IV as distant metastatic disease .…”
Section: Introductionmentioning
confidence: 99%
“…6,7 There is no evidence that the histological features correlate with the clinical outcome. 6,[8][9][10] Merkel cell carcinoma Stage I is defined as tumours ≤ 2 cm, Stage II as >2 cm, stage III as regional nodal disease, and stage IV as distant metastatic disease. 11 In general, lower stage disease is associated with better overall survival.…”
Section: Introductionmentioning
confidence: 99%
